单位:[1]Department of Hepatology and Liver Transplantation, Institute of Liver and Biliary Sciences, D1 Vasant Kunj, New Delhi 110070, India[2]Department of Medicine, Ziauddin University Hospital, Karachi, Pakistan[3]Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran[4]Botkin Infectious Diseases Hospital, Saint Petersburg, Russia[5]Department of Gastroenterology, Ankara University School of Medicine, Ankara, Turkey[6]Department of Hepatology, Nork Clinical Hospital of Infectious Disease, Yerevan, Armenia[7]Liver Research Center, Beijing Friendship Hospital, Capital Medial University, Beijing, China临床科室国家中心肝病分中心首都医科大学附属北京友谊医院[8]Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea[9]Hepatopancreatobiliary Center, School of Clinical Medicine, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China[10]Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore[11]Department of Internal Medicine and Hepatitis Research Center, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei City, Taiwan[12]Division of Liver Diseases Jinan Infectious Disease Hospital, Shandong University, Jinan, China[13]Department of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh[14]Eijkman Institute for Molecular Biology, Jakarta, Indonesia[15]Department of Medicine, Faculty of Medicine, University of Kelaniya, Ragama, Colombo, Sri Lanka[16]Department of Gastroenterology, Yamanashi Central Hospital, Yamanashi, Japan[17]University of Tokyo, Tokyo, Japan[18]Fatima University Medical Center Manila, Manila, Philippines[19]French Agency for Research on AIDS and Viral Hepatitis, University of Health Science, Phnom Penh, Cambodia[20]Division of Gastroenterology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand[21]Department of Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, New Delhi, India[22]Department of Medicine, University of Melbourne, Melbourne, VIC, Australia[23]Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea[24]Li Shu Fan Medical Foundation Professor in Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong[25]Department of Epidemiology, School of Public Health, Fudan University, Shanghai, China[26]Department of Laboratory Medicine, Department of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China
Hepatitis B virus (HBV) infection still remains a major public health issue in the Asia-Pacific region. Most of the burden of HBV-related disease results from infections acquired in infancy through perinatal or early childhood exposure to HBV in Asia-Pacific. Hepatitis B during pregnancy presents unique management issues for both the mother and fetus. These APASL guidelines provide a comprehensive review and recommendations based on available evidence in the literature, for the management of females with HBV infection through every stage of pregnancy and postpartum. These also address the concerns, management challenges, and required follow-up of children born to hepatitis B-positive mothers.
第一作者单位:[1]Department of Hepatology and Liver Transplantation, Institute of Liver and Biliary Sciences, D1 Vasant Kunj, New Delhi 110070, India
通讯作者:
推荐引用方式(GB/T 7714):
Kumar Manoj,Abbas Zaigham,Azami Milad,et al.Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy[J].HEPATOLOGY INTERNATIONAL.2022,16(2):211-253.doi:10.1007/s12072-021-10285-5.
APA:
Kumar Manoj,Abbas Zaigham,Azami Milad,Belopolskaya Maria,Dokmeci A K...&Zhou Y H.(2022).Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy.HEPATOLOGY INTERNATIONAL,16,(2)
MLA:
Kumar Manoj,et al."Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy".HEPATOLOGY INTERNATIONAL 16..2(2022):211-253